News

Echelon Biosciences Inc. is pleased to join the NIH Glycoscience Common Fund Program listing of Companies w/ Glycoscience Catalogs.  Echelon …

Echelon joins NIH Common Fund Resources List Read More »

Utah’s flourishing Life Sciences Industry was proudly on display at the 2023 Annual Life Sciences Day on Capitol Hill. Echelon …

Echelon Biosciences participates at Life Sciences Day with BioUtah Read More »

Echelon Biosciences Inc. (EBI) is excited to announce a new partnership with ProBioscience Technologies for product distribution in Singapore and …

Echelon Biosciences announces partnership with ProBioscience Technologies for distribution in Southeast Asia Read More »

November, 15, 2022 – Salt Lake City, UT, USA – Echelon Biosciences announces that it has been selected as the 2022 …

Echelon Biosciences selected as the 2022 Bioz “Rising Star” ELISA Winner Read More »

This year marks a major milestone for Echelon Biosciences (EBI).  We are celebrating our 25th Anniversary as a company. EBI’s …

25 Years of Supporting Science Read More »

(Salt Lake City, UT and Paris, FR, April 13, 2021) – HTL, the worldwide leader in biotechnology solutions using hyaluronic …

HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership Read More »

Echelon Biosciences is proud to announce a new partnership with Biotechno Labs for product distribution in India. Based in New …

Echelon Biosciences partners with Biotechno Labs for distribution in India Read More »

A new SBIR grant through the Department of Defense aims to develop new prophylactic treatments for exposure to chemical warfare …

Echelon Biosciences awarded DoD grant to establish a production platform for countermeasures against chemical warfare agents Read More »